# Caffeine/Propranolol Intervention for Acute Migraine

> **NCT01080677** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 60 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** caffeine/propranolol combination tablet
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01080677
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080677, "Caffeine/Propranolol Intervention for Acute Migraine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01080677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*